林奇综合征中进展期结直肠肿瘤的发病率和患病率
该美国队列纳入132例林奇综合征患者,评估监测性结肠镜下进展期肿瘤的患病与发病情况。进展期腺瘤患病率10.7%、发病率6.1%,浸润性结直肠癌患病率0%、发病率2.3%。发病的结直肠癌均见于MSH2和MLH1致病变异携带者。
要点
- 进展期腺瘤患病率10.7%,发病率6.1%。
- 浸润性结直肠癌患病率0%,发病率2.3%。
- 发病的结直肠癌均见于MSH2和MLH1致病变异携带者。
核心结论
- 在美国林奇综合征队列中,年度监测期间进展期肿瘤罕见发生。
- 结直肠癌仅见于MSH2和MLH1致病变异携带者。
- 进展期腺瘤的发生与致病变异类型或林奇综合征癌症史无关。
- 作者认为需前瞻性研究来证实这些发现。
研究设计与样本
- 纳入至少接受1次监测性结肠镜检查且无浸润性结直肠癌个人史或结直肠手术史的林奇综合征患者。
- 共纳入132例患者,其中112例同时接受了患病期和发病期监测。
- 患病期肿瘤定义为胚系确诊林奇综合征前6个月内发生,发病期肿瘤定义为确诊后6个月及以上发生。
- 评估进展期腺瘤、结直肠癌以及错配修复致病变异和典型林奇综合征癌症史对结局的影响。
主要发现
- 患病期和发病期监测的中位检查间隔分别为0.88年和1.06年,中位监测持续时间分别为3.1年和4.6年。
- 进展期腺瘤患病率为10.7%,发病率为6.1%。
- 浸润性结直肠癌患病率为0%,发病率为2.3%。
- 所有发病的结直肠癌均发生于MSH2和MLH1致病变异携带者,仅1例(0.7%)在本中心监测期间发生。
- 进展期腺瘤在两类林奇综合征癌症史队列中均可检出,并见于所有致病变异类型。
局限性
- 作者认为需前瞻性研究来证实这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Lynch syndrome (LS) is the most common hereditary cause of colorectal cancer (CRC) and endometrial cancer (EC). Although colonoscopy reduces CRC in LS, the protection is variable. We assessed the prevalence and incidence of neoplasia in LS during surveillance colonoscopy in the United States and factors associated with advanced neoplasia. METHODS: Patients with LS undergoing ≥1 surveillance colonoscopy and with no personal history of invasive CRC or colorectal surgery were included. Prevalent and incident neoplasia was defined as occurring <6 months before and ≥6 months after germline diagnosis of LS, respectively. We assessed advanced adenoma (AA), CRC, and the impact of mismatch repair pathogenic variant (PV) and typical LS cancer history (personal history of EC and/or family history of EC/CRC) on outcome. RESULTS: A total of 132 patients (inclusive of 112 undergoing prevalent and incident surveillance) were included. The median examination interval and duration of prevalent and incident surveillance was .88 and 1.06 years and 3.1 and 4.6 years, respectively. Prevalent and incident AA were detected in 10.7% and 6.1% and invasive CRC in 0% and 2.3% of patients. All incident CRC occurred in MSH2 and MLH1 PV carriers and only 1 (.7%) while under surveillance in our center. AAs were detected in both LS cancer history cohorts and represented in all PVs. CONCLUSIONS: In a U.S. cohort of LS, advanced neoplasia rarely occurred over annual surveillance. CRC was diagnosed only in MSH2/MLH1 PV carriers. AAs occurred regardless of PV or LS cancer history. Prospective studies are warranted to confirm our findings.
引用
- Sleiman J, Farha N, Beard J, et al. Incidence and prevalence of advanced colorectal neoplasia in Lynch syndrome. Gastrointest Endosc. 2023. PMID: 37031913. doi:10.1016/j.gie.2023.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。